Alligator Bioscience AB Stock
Stocks
ATORX
SE0024173637
Biotechnology & Medical Research
OTC Markets Traded|
Delayed
Nasdaq Stockholm
16:33:58 19/10/2026 +03
|
5-day change | 1st Jan Change | ||
| 0.0129 SEK | -2.27% |
|
-13.10% | -96.26% |
| 09-07 | Alerts on Alligator Bioscience conducting rights issue withdrawn | RE |
| 09-01 | Alligator Bioscience shares trade today on Nasdaq Stockholm ex-rights for units in rights issue | FW |
| Market Cap | 8.29M 837K 744K 690K 628K 1.18M 79.46M 1.2M 3.25M 41.46M 3.14M 3.08M 132M | P/E 2026 * |
-
| P/E 2027 * | - |
|---|---|---|---|---|---|
| Enterprise Value | 8.29M 837K 744K 690K 628K 1.18M 79.46M 1.2M 3.25M 41.46M 3.14M 3.08M 132M | EV / Sales 2026 * |
1.41x | EV / Sales 2027 * | 0.17x |
| Free-Float |
38.38% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq Stockholm
| ATORX | Delayed | |
CBOE
| ATORXs | Real-time | |
|
OTC Markets
| ALLGF | Delayed | |
|
Deutsche Boerse AG
| 7AL0 | Delayed | |
|
CBOE
| 0RK9 | Real-time | |
|
Börse Stuttgart
| 7AL0 | Delayed |
Last Transcript: Alligator Bioscience AB
| 1 day | -4.55% | ||
| 1 week | -13.10% | ||
| Current month | -37.00% | ||
| 1 month | -40.00% | ||
| 3 months | -93.35% | ||
| 6 months | -96.10% | ||
| Current year | -96.26% |
| 1 week | 0.01 |  | 0.02 |
| 1 month | 0.01 | | 0.02 |
| Current year | 0.01 | | 0.49 |
| 1 year | 0.01 | | 3.56 |
| 3 years | 0.01 | | 1,568 |
| 5 years | 0.01 | | 3,000 |
| 10 years | 0.01 | | 40,100 |
| Manager | Title | Age | Since |
|---|---|---|---|
Søren Bregenholt
CEO | Chief Executive Officer | 55 | 01/06/2021 |
Johan Gileus
DFI | Director of Finance/CFO | 61 | 12/08/2024 |
Tom Moore
CTO | Chief Tech/Sci/R&D Officer | - | 01/04/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 55 | - | |
| Director/Board Member | 64 | 01/06/2021 | |
Denise Goode
BRD | Director/Board Member | 68 | 09/05/2022 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 3/5/25 A | Buy | Chairman | 800,000 | 0.0047% | ||
| 3/5/25 A | Buy | Chairman | 77,319 | 0.0005% | ||
| 3/5/25 A | Sell | Chairman | 1,658,134 | 0.0098% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.27% | -13.10% | -99.62% | -100.00% | 837K | |
| +1.52% | -7.16% | +51.66% | +67.41% | 65B | |
| +0.78% | +6.24% | +10.27% | +78.30% | 51.2B | |
| 0.00% | -0.79% | -0.36% | +61.36% | 51.19B | |
| -0.55% | +2.17% | +26.34% | +43.45% | 43.93B | |
| +0.39% | +6.74% | +17.39% | +135.71% | 41.96B | |
| +0.51% | -6.44% | +235.97% | +525.71% | 38.14B | |
| +2.16% | +10.36% | +18.92% | +59.70% | 33.24B | |
| -0.90% | -10.49% | +37.09% | +1.80% | 25.2B | |
| +1.42% | +2.90% | +28.82% | +28.85% | 22.5B | |
| Average | +0.10% | -1.25% | +32.65% | +90.23% | 37.24B | |
| Weighted average by Cap. | +0.64% | +0.04% | +45.56% | +112.43% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 5.9M 596K 530K 491K 447K 843K 56.54M 856K 2.31M 29.51M 2.24M 2.19M 94.06M | 49.7M 5.02M 4.46M 4.13M 3.76M 7.1M 476M 7.21M 19.49M 249M 18.83M 18.43M 792M |
| Net income | -15.2M -1.53M -1.36M -1.26M -1.15M -2.17M -146M -2.21M -5.96M -76.01M -5.76M -5.64M -242M | 28.9M 2.92M 2.59M 2.4M 2.19M 4.13M 277M 4.19M 11.33M 145M 10.95M 10.72M 461M |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 19/10/26 | SEK 0.0129 | -2.27% | 4,673,048 |
| 16/10/26 | SEK 0.0132 | +1.54% | 22,150,075 |
| 15/10/26 | SEK 0.0130 | -2.99% | 12,509,086 |
| 14/10/26 | SEK 0.0134 | -8.84% | 75,997,507 |
| 13/10/26 | SEK 0.0147 | +1.38% | 92,601,964 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Annual profits - Rate of surprise
- Stock Market
- Stocks
- ATORX Stock
Select your edition
All financial news and data tailored to specific country editions
